NanoHive Medical, a Boston, MA-based company which specialises in 3D-printed titanium spinal interbody fusion devices, raised $7M in Series C funding.
Backers were not disclosed.
The company intends to use the funds to expand the U.S. commercial organization and its innovative Hive™ portfolio of Soft Titanium® spinal interbody fusion devices by way of product line-extensions, product launches, and “smart” sensor implant delivery research and development, enter in select international markets and expand strategic partnerships.
Led by CEO Patrick O’Donnell, NanoHive Medical is an innovator in 3D printed spinal interbody fusion implants and instrumentation. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to fusion constructs and efficacious clinical experiences.
The company also added Greg Hoffman and David Scott to its Managing Directors Board.
FinSMEs
05/08/2024